Many Feel US Health Care Puts Profit Over Patients
Drug Topics
NOVEMBER 28, 2022
The fight to put the consumer first in health care remains as many Americans feel the industry is still putting the mighty dollar ahead of patients.
Mon.Nov 28, 2022
201 
Lung Cancer Screening Significantly Increases 20-Year Survival Rate
Pharmacy Times
NOVEMBER 28, 2022
Patients with lung cancer in an early-intervention lung screening program were found to have a survival rate nearly 20-times longer than patients with a late-stage diagnosis.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Looking at Barriers to Childhood Vaccinations
Drug Topics
NOVEMBER 28, 2022
A recent poll showed that some parents do not discuss vaccines with their child’s regular doctor, with many choosing to not have their child receive any vaccines.
Walgreens to Eliminate Task-Based Metrics in Evaluation of Pharmacy Staff
Pharmacy Times
NOVEMBER 28, 2022
Walgreens plans to focus on improving pharmacy staffing and retaining and rewarding current staff.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Global Measles Threat Increases due to Decline in Vaccine Coverage
Drug Topics
NOVEMBER 28, 2022
The COVID-19 pandemic disrupted routine immunization programs around the world.
More vaccinated than unvaccinated died from COVID-19 in August: analysis
Fierce Healthcare
NOVEMBER 28, 2022
More vaccinated than unvaccinated died from COVID-19 in August: analysis. fdiamond. Mon, 11/28/2022 - 16:34.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: Anti-amyloid drugs and the mystery of treatment-associated brain shrinkage
STAT
NOVEMBER 28, 2022
Eisai’s announcement that lecanemab, its antibody drug for Alzheimer’s disease that targets the buildup of amyloid protein in the brain, modestly slowed cognitive decline in a Phase 3 trial offers hope to people with Alzheimer’s disease. But what I’ll be looking for in the final data — which have not yet been presented or published — is whether the brain shrinkage seen in the Phase 2 trial remains.
5 enduring mysteries of the Barry and Honey Sherman murders
PharmaVoice
NOVEMBER 28, 2022
After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.
Aprocitentan Significantly Lowers Blood Pressure in Patients with Difficult-to-Control Hypertension
Pharmacy Times
NOVEMBER 28, 2022
Patients with difficult-to-control hypertension have greater risk of heart attack, stroke, end-stage renal disease, and heart failure.
Examining Low-Dose Oral Minoxidil for Hair Growth
Drug Topics
NOVEMBER 28, 2022
More and more, clinicians are using oral minoxidil to treat patients with hair loss. Is it working?
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Opinion: Minimizing administrative harm: a key step to improving health care
STAT
NOVEMBER 28, 2022
Late on a Friday, I sit reviewing some of my patients’ old medical records instead of heading home to be with my family. I’ll likely be doing it next Friday, and the one after that. This wasn’t my idea. The health system I work for discovered that some patients for whom CT scans were ordered never got them over the ensuing two to three years.
C4XD and AstraZeneca enter $402m deal to develop respiratory disease therapy
Pharmaceutical Technology
NOVEMBER 28, 2022
C4X Discovery (C4XD) and AstraZeneca have entered an exclusive global licensing agreement worth up to $402m to develop oral therapy to treat inflammatory and respiratory ailments. The deal has been signed to develop the C4X NRF2 Activator programme for these ailments. Under the agreement, AstraZeneca will be responsible for the development and marketing of oral therapy for inflammatory and respiratory diseases with a key focus on chronic obstructive pulmonary disease (COPD).
WHO to phase out the name ‘monkeypox’ for ‘mpox’
STAT
NOVEMBER 28, 2022
The World Health Organization said Monday it will phase out the name of the disease monkeypox over the next year, replacing it with the term mpox. The decision follows widespread calls for changing the name since the current international outbreak of the disease was first detected last May. The name of the disease and even the virus itself has been deemed by many to exacerbate the stigma attached to the infection — a sentiment the WHO referenced in the statement it issued announcing the c
Supporting the era of green pharmaceuticals in the UK
pharmaphorum
NOVEMBER 28, 2022
According to a report by the Office of Health Economics (OHE), commissioned by the Association of the British Pharmaceutical Industry (ABPI), immediate action must be taken by governments, health systems, and companies to secure the era of green pharmaceuticals. ‘Supporting the era of green pharmaceuticals in the UK’ highlights that, while Britain can play a leading role in the sustainability agenda for pharmaceuticals, action must also be taken on a global scale to ensure impact.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Google Health strikes deal with iCAD to commercialize mammography AI
Fierce Healthcare
NOVEMBER 28, 2022
Google Health strikes deal with iCAD to commercialize mammography AI. hlandi. Mon, 11/28/2022 - 12:49.
STAT+: mRNA startup Strand Therapeutics raises millions to test targeted cancer therapies
STAT
NOVEMBER 28, 2022
When Jacob Becraft addressed a bustling party of a hundred-plus employees, friends, and investors at his startup’s lab last month, he credited messenger RNA for bringing everyone back together in one room. His remarks carried a double meaning. Yes, the mRNA vaccines had allowed the large group to gather in person — not a mask in sight.
In face of 'tripledemic,' masking mandates might make a comeback
Fierce Healthcare
NOVEMBER 28, 2022
In face of 'tripledemic,' masking mandates might make a comeback. fdiamond. Mon, 11/28/2022 - 14:46.
STAT+: ‘Skinny labels’ on biosimilar medicines saved Medicare $1.5 billion over a recent five-year period
STAT
NOVEMBER 28, 2022
A hotly contested provision of a federal law designed to speed copycat drugs to market and foster competition saved Medicare $1.5 billion from 2015 to 2020 — or nearly 5% of the $30.2 billion spent by the health care program — on just five medicines during that period, according to a new analysis. The provision is known as skinny labeling , which refers to a move by a company that seeks regulatory approval to market a generic or biosimilar medicine for a specific use, but not for o
Shoppers spend $11.3B on Cyber Monday
Drug Store News
NOVEMBER 28, 2022
According to final Adobe Analytics data, consumers spent a total of $11.3 billion on Cyber Monday, representing 5.8% growth year-over-year from $10.7 billion.
STAT+: Axsome drug reduces agitation in Alzheimer’s patients, data show
STAT
NOVEMBER 28, 2022
A drug developed by Axsome Therapeutics significantly reduced a common side effect of Alzheimer’s disease — agitation — the company announced Monday. The therapy, AXS-05, met its primary goal of delaying time to relapse and preventing patients from relapsing. Patients taking the drug had a 3.6-fold lower risk of relapse overall, compared to placebo.
The best SingleCare reviews this November
The Checkup by Singlecare
NOVEMBER 28, 2022
When you think about November, turkey, stuffing, and pumpkin pie probably comes to mind. But did you know that it’s also National Diabetes Month? If you’re one of the 37 million Americans living with the condition, SingleCare’s blog The Checkup has you covered. Read about the best diet for insulin resistance , evidence-backed natural diabetes remedies , and everything you need to know about diabetes complications. .
Lessons from a thriving physical therapist to a younger self just learning about multiple sclerosis
STAT
NOVEMBER 28, 2022
“Living With” explores the contours of life with chronic illness, from the prelude to diagnosis to new patterns of living, to wrestling with big questions about illness and health. A little under 10 years ago, Leigh Krauss was almost done with her schooling to become a physical therapist. A former guard on the women’s basketball team at Trinity College in Hartford, Conn., she had always been active and healthy.
Increasing sustainability in pharma requires an industry-wide effort
pharmaphorum
NOVEMBER 28, 2022
With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact. The past eight years are set to be the eight warmest on record. The rate of sea level rise has doubled since 1993; the past two and half years alone represent 10% of the overall rise in sea level since records began 30 years ago.
China eases Covid rules after wide protests of lockdowns
STAT
NOVEMBER 28, 2022
BEIJING — Chinese authorities eased some anti-virus rules but affirmed their severe “zero Covid” strategy Monday after protesters demanded President Xi Jinping resign in the biggest show of opposition to the ruling Communist Party in decades. The government made no comment on the protests or the criticism of Xi, but the decision to ease at least some of the restrictions appeared to be aimed at quelling anger.
How Do You Become an Anesthesiologist?
Board Vitals - Pharmacist
NOVEMBER 28, 2022
Anesthesiologists are medical doctors who specialize in the administration of anesthesia. These specialists work together with surgeons, surgical technologists, and other medical professionals to ensure patients are comfortable and healthy before, during, and after surgical procedures. Like with most specialties, the road to becoming an anesthesiologist is long and challenging to ensure practitioners are prepared to deliver the utmost quality in patient care.
STAT+: Pharmalittle: Second clinical trial death may be linked to Eisai-Biogen Alzheimer’s drug; pharma presses the U.K. over ‘out of control’ levy
STAT
NOVEMBER 28, 2022
Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on this side of the pond — was relaxing and invigorating, because that oh-so-familiar routine of online meetings, phone calls, and deadlines has, of course, returned. But what can you do? The world, such as it is, keeps spinning.
Exploring a united vision for British pharma at Anthropy – the pharmaphorum podcast
pharmaphorum
NOVEMBER 28, 2022
Anthropy 2022 brought climate change to industry in Cornwall in (a very wet and windy) early November, settling cosily into the truly eco-minded environs of the Eden Project and firing up fervent and necessary conversations on sustainability, accessibility, and action plans. Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and discuss just how exciting it was to bring to vibrant and discursive life the ethos of Anthropy – a unit
STAT+: The secret to longer, healthier life? Ambitious new trial focuses on ‘super agers’ and seeks thousands of families.
STAT
NOVEMBER 28, 2022
Dr. Thomas Perls has for decades studied so-called super agers, people who live deep into their 90s and beyond, essentially unburdened by the typical diseases of old age. He is convinced that the secret to this remarkable longevity is buried in people’s genes and passed down through generations. But which genes harbor this power? And if researchers pinpoint the right genes amid thousands in a person’s body, could that knowledge be harnessed to develop drugs that mimic t
Gateway Genomics makes DNA-based prenatal, pediatric information accessible
Drug Store News
NOVEMBER 28, 2022
Drug Store News caught up with Sarah Cacia, director of retail business development at Gateway Genomics, to get the scoop and to find out what’s next for the brand.
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy
Fierce Pharma
NOVEMBER 28, 2022
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy. ntaylor. Mon, 11/28/2022 - 10:11.
Framework to enable re-use of patient clinical data
European Pharmaceutical Review
NOVEMBER 28, 2022
FACILITATE , (FrAmework for ClInicaL trIal participants’ daTA reutilisation for a fully Transparent and Ethical ecosystem) is a patient-driven legal framework that intends to help return clinical trial data to study participants, ready for re-use in further research or healthcare practice. Part of a four-year project, aided by 27 partners from both EU and non-EU Member States, the framework will help develop technological solutions to support the sharing and re-use of the data.
UK Government to fund research into new obesity treatments
Pharmaceutical Technology
NOVEMBER 28, 2022
The UK Government has announced funds worth $24.17m (£20m) to conduct research for developing new obesity therapies and technologies. These therapies and digital tools have been demonstrated to aid people in shedding 20% of their weight. Every year, obesity costs a staggering $7.2bn (£6bn) to the UK National Health Service (NHS), and by 2050, the figure is expected to increase to more than $11.7bn (£9.7bn) per year.
AllianceRx Walgreens Pharmacy launches corporate giving program
Drug Store News
NOVEMBER 28, 2022
St. Jude Children’s Research Hospital was chosen as the first recipient of proceeds from the AllianceCares' program’s semi-annual giving campaign.
Pharmacy Students Share Their Unique Experiences, Perspectives on Instagram
Pharmacy Times
NOVEMBER 28, 2022
Instagram offers a myriad of ways to share content and connect with others.
Let's personalize your content